NCT07428486 2026-05-07A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic LeukemiaM.D. Anderson Cancer CenterPhase 1 Withdrawn